Cargando…
Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice
Type 1 diabetes is a metabolic disease caused by autoimmunity towards β-cells. Different strategies have been developed to restore β-cell function and to reestablish immune tolerance to prevent and cure the disease. Currently, there is no effective treatment strategy to restore endogenous insulin se...
Autores principales: | Pujol-Autonell, Irma, Ampudia, Rosa M., Monge, Pau, Lucas, Anna M., Carrascal, Jorge, Verdaguer, Joan, Vives-Pi, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608187/ https://www.ncbi.nlm.nih.gov/pubmed/23555060 http://dx.doi.org/10.1155/2013/346987 |
Ejemplares similares
-
Efferocytosis Promotes Suppressive Effects on Dendritic Cells through Prostaglandin E2 Production in the Context of Autoimmunity
por: Pujol-Autonell, Irma, et al.
Publicado: (2013) -
Phosphatidylserine-Liposomes Promote Tolerogenic Features on Dendritic Cells in Human Type 1 Diabetes by Apoptotic Mimicry
por: Rodriguez-Fernandez, Silvia, et al.
Publicado: (2018) -
Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017) -
Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8(+)T Effector Memory Subset
por: Alonso, Núria, et al.
Publicado: (2015) -
How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review
por: Vives-Pi, Marta, et al.
Publicado: (2015)